Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2005;36:1544-1550
Published online before print June 2, 2005, doi: 10.1161/01.STR.0000169903.09253.c7
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/7/1544    most recent
01.STR.0000169903.09253.c7v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yanamoto, H.
Right arrow Articles by Kikuchi, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yanamoto, H.
Right arrow Articles by Kikuchi, H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*POTASSIUM CHLORIDE
Related Collections
Right arrow Other Stroke Treatment - Medical

(Stroke. 2005;36:1544.)
© 2005 American Heart Association, Inc.


Original Contributions

Induced Spreading Depression Activates Persistent Neurogenesis in the Subventricular Zone, Generating Cells With Markers for Divided and Early Committed Neurons in the Caudate Putamen and Cortex

Hiroji Yanamoto, MD, DMSc; Susumu Miyamoto, MD, DMSc; Norimitsu Tohnai, PhD; Izumi Nagata, MD, DMSc; Jing-Hui Xue, MD, PhD; Yoshikazu Nakano, BSc; Yukako Nakajo, MSc Haruhiko Kikuchi, MD, DMSc

From the Laboratory for Cerebrovascular Disorders (H.Y., N.T., J.-H.X., Y.N., Y.Nakajo), Research Institute of the National Cardiovascular Center, Department of Cerebrovascular Surgery (H.Y., S.M., I.N.), Hospital of the National Cardiovascular Center (H.K.), Japan; and the Laboratory for Basic Science (Y.Nakajo), Rakuwakai Otowa Hospital, Kyoto, Japan.

Correspondence to H. Yanamoto, MD, DMSc, Laboratory for Cerebrovascular Disorders, Research Institute of National Cardiovascular Center, 5-7-1 Fujishiro-dai, Suita, 565-8565 Japan. E-mail hyanamot{at}res.ncvc.go.jp


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background and Purpose— Status epilepticus and cerebral ischemia stimulate persistent neurogenesis in the adult brain, but both conditions cause neuronal damage. We determined whether spreading depression, a common epiphenomenon of these conditions, stimulates persistent neurogenesis.

Methods— We analyzed the effect of KCl-induced spreading depression on persistent neurogenesis and the spatio-temporal distribution of cells exhibiting immunohistochemical markers for divided and early committed neurons (new neurons) in the adult rat brain.

Results— After induction of spreading depression for 48 hours, the density of mitotic cells, divided cells, and new neurons in the subventricular zone increased at days 1 to 3, days 3 to 6, and day 6, respectively (P<0.05). The divided cell density in the rostral migratory stream and the stream size increased at day 12 (P<0.001). Vehicle (saline) infusion or induction of spreading depression for 4 hours only did not increase the divided cell density, but the latter increased new neuron density in the subventricular zone (P<0.001). Double-labeled new neuron-like cells also appeared in the caudate putamen or cortex in ectopic fashion at day 3, with dramatic increases at days 6 and 12. Administration of the NMDA receptor antagonist, MK-801, which inhibits the propagation of spreading depression, abolished the increase in new neurons in the subventricular zone and the appearance of ectopic new neuron-like cells after 48-hour KCl infusion. There was no neuronal damage, as evidenced by mature neuron density, neurite density, and apoptotic cell appearance after spreading depression for 48 hours.

Conclusions— Spreading depression has the potential to stimulate persistent neurogenesis or to produce ectopic new neuron-like cells.


Key Words: cell differentiation • cell division • membrane potential • progenitor cells


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
In the adult mammalian brain, neurogenesis persists in the dentate gyrus subgranular zone1 and in the forebrain subventricular zone (SVZ).2,3 Recently, chemoconvulsant-induced status epilepticus and cerebral ischemia have been found to stimulate persistent neurogenesis by increasing divided cell densities, promoting a majority of them to neuronal differentiation in adult rodents.4–6 Neuronal cell death has been considered common under these harmful conditions, but cerebral lesioning did not stimulate persistent neurogenesis.7

Spreading depression (SD), found during epileptogenic stimulation,8 is characterized by a wave of fully reversible cellular depolarization, propagating throughout the cortex, into the thalamus, caudate putamen, and hippocampus.9 Various cerebral conditions that increase regional [K+]e to the depolarizing threshold (epileptic discharges and anoxia/ischemia) induce SD.8,9 Focal cerebral ischemia caused 52 to 78 events of SD in 24 hours,10 and a specific cerebral injury caused epileptic seizure activities on electroencephalography, or 68 SDs in 48 hours.11 Thus, repetitive SDs are a common epiphenomenon of the persistent neurogenesis-stimulating conditions.

In the present study, we investigated the effect of 48-hour KCl-induced SDs on persistent neurogenesis, by analyzing cells in the SVZ, the rostral migratory stream (RMS), the normal route for differentiating new neurons to the olfactory bulb, the caudate putamen (CPu), and the frontoparietal cortex (FPC) using immunohistochemical techniques.


*    Materials and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Materials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
The experimental protocols were designed in accordance with the animal experimental guidelines established by the animal research committee at NCVC. All efforts were made to minimize suffering and the number of animals used.

Experimental Groups and Induction of SD
Sprague-Dawley rats (SLC, Kyoto, Japan), 8 to 9 weeks old, were randomly divided into 5 groups: 48-hour KCl-treated (48-hour SD), 4-hour KCl-treated (4-hour SD), 48-hour KCl treatment with administration of the noncompetitive N-methyl-D-aspartate receptor antagonist (MK-801) (Sigma, St Louis, Mo), which inhibits propagation of SD,12 48-hour saline-treated (vehicle), and an untreated normal control group (N).

In the treated groups, an osmotic mini-pump (Alzet 2001; Alza) with the infusion needle was implanted in the primary somatosensory area in the cortex (Figure 1a) so that 4 mol/L KCl or saline could be infused continuously at a rate of 1.0 µL/h.9,13 The reliability of this method was established in our previous study: repetitive SD waves at 36-minute intervals (average) were confirmed.13 The physiological parameters were within the normal range at the end of and for at least 21 days after 48 hours of KCl-induced SD (unpublished data).



View larger version (78K):
[in this window]
[in a new window]
 
Figure 1. The KCl infusion site, the analyzed SVZ or RMS, and alteration of PCNA+ cells. a, The KCl infusion site at Bregma –1.0 mm. b, The level of the SVZ, Bregma +0.2 mm. c, The level of the RMS, Bregma +2.7 mm. d, PCNA+ cells in the SVZ in the N or 48-hour SD group at day 3. Mitotic figures (arrows) found at day 1. Magnification x600, originally. Bars: 20 µm. e, Density of PCNA+ cells or mitotic cells (f) in the SVZ after 48-hour SD. Ndl indicates needle location; cc, corpus callosum; LV, lateral ventricle; ACg,: anterior cingulate cortex; V-VI, cortical layers V-VI. Arrowheads indicate borders of cortical areas. Normal or N, N group; vent., forebrain lateral ventricle; *P<0.05, compared with the N group.

Preparation of Tissue Sections
Brains were removed under deep anesthesia: from the 48-hour SD, or vehicle group at day 0 (=day of pump removal), 1, 3, 6, 9, or 12 (n=6, or 3 each); from the 4-hour SD (n=6), or MK-801 group [intraperitoneal injections with 2 or 4 mg/kg per shot (n=6 each), 1 hour before and 24 hours after KCl-pump implantation] at day 6; and from the N group (n=10). The protocol specified that the 4-hour SD or MK-801 group be euthanized at day 6, because the density of new neurons in the 48-hour SD group increased at day 6 in our pilot study.

Each brain was cut into 2-mm-thick coronal slabs and immersed in methanol Carnoy’s solution. The paraffin-embedded tissues were sliced into 7 sets of two 3-µm-thick coronal sections, 12 µm apart, at the SVZ (Figure 1b). In these sections, 3 sets were used for analysis of the CPu and FPC (Figure 1b). At RMS (Figure 1c), 2 sets were obtained in the same manner. This slice thinness precludes any pseudo-positive double-labeled images.

Immunohistochemistry and BrdUrd Administration
Up to the time of brain removal, all rats received 5-bromo-2'-deoxyuridine (BrdUrd) (B-5002; Sigma) via drinking water (1 mg/mL)14 starting on the day of pump implantation for a maximum of 120 hours (<120 hours if brain removal occurred earlier). BrdUrd is incorporated into the dividing cell during the S-phase and labels every divided cell. It was established that the volume of drinking water did not differ significantly among the groups, and ranged from 80 to 110 mg/kg per day. To confirm the reliability of this method, BrdUrd-labeled cell densities in the SVZ after intraperitoneal injections of 50 mg/kg BrdUrd, every 12 hours for 120 hours, beginning at KCl pump implantation (BrdUrd control) (n=6), were also analyzed at day 6. In the MK-801 group, intraperitoneal BrdUrd administration was performed, because the drug temporarily impaired drinking behaviors in our pilot study.

The primary antibodies used were monoclonal mouse anti-PCNA (clone PC10; Upstate Biotechnology, Lake Placid, NY), 1:100, for detection of mitotically active cells;15 monoclonal mouse anti-BrdUrd (clone 3D4; BD Biosciences, San Jose, Calif), 1:150, for divided cells;16 polyclonal rabbit anti-class III ß-tubulin (ß-tubulin III) (PRB-435P; BAbCO, Richmond, Calif), 1:200, for cells committed to a neuronal lineage,17 polyclonal goat anti-double cortin (C-18; Santa Cruz Biotechnology, Santa Cruz, Calif), 1:100 for migrating neuroblasts,18 and polyclonal rabbit anti-GFAP (Dako, Glostrup, Denmark), 1:200, for astrocytes. Immunoreactivity was revealed by the labeled streptavidin-biotin-HRP method (LSAB kit; Dako) with hematoxylin as counter-stain, or by immunofluorescence (FITC or TRITC) using confocal laser scan microscopy. Individual control staining in the absence of primary antibodies abolished immunoreactivity (data not shown).

Cell Densities in the SVZ
PCNA+ cells, cells in mitosis (with visualized chromosomes), BrdUrd+ cells, or BrdUrd–ß-tubulin III double-labeled (BrdUrd+/ß-tubulin III+) cells in the SVZ within the predetermined frame (1200x600 µm) (Figure 1b) were counted at x600 (Mac Scope; Mitani Co) in the 48-hour SD, vehicle, and N groups. The 4-hour SD, MK-801, and BrdUrd control groups were also analyzed for BrdUrd+/ß-tubulin III+ cell density. The size of the targeted SVZ was measured for calculation of cell density. The total (hematoxylin+) cell number in the SVZ was counted for calculation of each cell ratio.

Cell Density in the RMS, Caudate Putamen, or Cortex
The density of BrdUrd+ cells in the RMS (Figure 1c) was calculated in the same manner as in the SVZ. The sectional area of the RMS was measured for each sample. In the CPu or FPC (Figure 1b), the density and the distribution of BrdUrd+/ß-tubulin III+ cells were analyzed at x600 in the 48-hour SD, vehicle, or MK-801 group.

Damage to the Cortex
Brain slices were stained using monoclonal mouse anti-NeuN (Chemicon), 1:100, for detection of mature neurons, Bodian’s silver method for neurofilaments in neurites, or terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL; ApopTag, Serologicals Co) for apoptotic cells, at days 1, 3, 6, and 12 after 48-hour SD. The total number of NeuN+ cells in the predetermined area in supplementary somatosensory area (Figure 1b) was counted at x100. Optical densities on Bodian’s silver stain were measured on histograms of the predetermined area in supplementary somatosensory area (presented as % of N group).

Quantification and Statistical Analysis
Cell density was calculated as the number of labeled cells divided by the analyzed area multiplied by the section thickness, with corrections for cell (nuclear) splitting between the sections19 (expressed per mm3). The mean target nuclear diameter in each location was used for correction.20 Statistical analysis was performed using 2-way (in SD and vehicle groups) or 1-way (in SD group) ANOVA. If multiple comparisons were indicated, the Bonferroni t test was applied. Data are presented as mean±SD.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
*Results
down arrowDiscussion
down arrowReferences
 
Cell Densities in the SVZ
PCNA+ cells, or cells in mitosis, increased after 48-hour SD, but not with the vehicle (Figure 1d to 1f), or in the contralateral SVZ (data not shown).

BrdUrd+, or BrdUrd+/ß-tubulin III+ cell density increased after 48-hour SD, whereas remained unchanged in vehicle group (Figure 2a and 2b), being independent of the duration of BrdUrd administration, ranging from 48 to 120 hours. The mean density of BrdUrd+/ß-tubulin III+ cells in the BrdUrd control was consistent with that after oral BrdUrd administration. The MK-801 treatments significantly reduced BrdUrd+/ß-tubulin III+ cell densities at day 6 in the SVZ after 48-hour KCl infusion (Figure 2c). In the contralateral SVZ, the BrdUrd+/ß-tubulin III+ cell densities at day 6 after 48-hour KCl infusion with the MK-801 treatment (2 mg or 4 mg/d) were consistent with those in the vehicle group at day 6 (data not shown).



View larger version (61K):
[in this window]
[in a new window]
 
Figure 2. Alteration of BrdUrd+ or BrdUrd+/ß-tubulin III+ cell densities in the SVZ or RMS and the effects of MK-801. a, Images of the untreated normal SVZ (upper panels) and the SVZ at day 6 (middle) and 12 (lower) after 48-hour SD. Magnification, x600, originally. Bars: 20 µm. b, Densities of BrdUrd+ cells or BrdUrd+/ß-tubulin III+ cells in the SVZ after 48-hour SD. c, BrdUrd+/ß-tubulin III+ cell densities in the BrdUrd oral (p.o.) or intraperitoneal (i.p.) administration group, and in the MK-801 group, at day 6 after 48-hour KCl-infusion. d, RMS size and the density of BrdUrd+ cells in the RMS after 48-hour SD. *P<0.05, compared with time-matched vehicle (b), N or BrdUrd control (c), or N group (d).

In the 4-hour SD group, BrdUrd+ cell density in the SVZ remained unchanged (data not shown), but the density of BrdUrd+/ß-tubulin III+ cells was significantly increased; 235±54, compared with the N group; 135±44 (x103) /mm3–SVZ (P<0.001).

Total Cell Density and Cell Ratio in the SVZ
The Table shows the alteration of total cell density and the individual cell ratio after 48-hour SD.


View this table:
[in this window]
[in a new window]
 
Total Cell Density and Individual Cell Ratio After 48-hour SD

RMS Size and Cell Density
RMS size and BrdUrd+ cell density in the RMS increased at day 12 after 48-hour SD (Figure 2d).

Cells Expressing GFAP in the SVZ
Cells in the cellular band underlying the ventricular ependymal cell layer expressed GFAP (Figure 3a). BrdUrd+ cells in cell clusters, surrounded by GFAP+ cells, were essentially GFAP-negative.



View larger version (40K):
[in this window]
[in a new window]
 
Figure 3. Confocal laser scan images for GFAP in the SVZ (a), new neuron-like cells in the CPu or FPC (b), and doublecortin in the SVZ (c) after 48-hour SD. a, BrdUrd+ (green) cells forming cell clusters and surrounding GFAP+ (red) cells at day 6 in the SVZ. b, BrdUrd+(green)/ß-tubulin III+ (red) cells in the CPu at day 12 (upper panels), in the FPC at day 12 (middle panels), or in the CPu at day 6 (lower panels). c, BrdUrd+ (green)/doublecortin+ (red) cells in the SVZ (upper panel), and cells close to the SVZ (arrows, and lower panels) at day 12. Magnification, x600, originally. Bars: (a) 20 µm, (b) 10 µm, (c) upper panel, 20 µm, lower panels, 10 µm.

Ectopic BrdUrd+/ß-tubulin III+ Cells
BrdUrd+/ß-tubulin III+ cells were found in the CPu or FPC after 48-hour SD (Figure 3b), but not in the vehicle group. The spatio-temporal distributions are illustrated in Figure 4a. The density increased at day 6 and/or day 12 in the CPu, or FPC restricted to the cortical layer V-VI and the anterior cingulate cortex. The MK-801 treatments abolished the ectopic BrdUrd+/ß-tubulin III+ cell appearance at day 6 (data not shown). After 48-hour SD, doublecortin was detected in many divided cells in, or in areas close to, the SVZ ({approx}<100 µm) (Figure 3c), but not in cells in the CPu or FPC during the observation period (data not shown).



View larger version (18K):
[in this window]
[in a new window]
 
Figure 4. Distribution of ectopic BrdUrd+/ß-tubulin III+ cells. a, BrdUrd+/ß-tubulin III+ cells (dots) in the CPu or FPC after 48-hour SD. Each diagram is a superimposed composite of 6 brain sections (one section per rat). b, BrdUrd+/ß-tubulin III+ cell densities after 48-hour SD, which were not detected in the vehicle group, revealed significant differences in the CPu (P<0.001) and FPC (P<0.002).

Damage to the Cortex
The cortical lamination, the density of mature neurons, and neurite density were not affected by 48-hour SD (Figure 5a to 5d). TUNEL-positive cells were observed only at the site of the KCl needle (Figure 5e).



View larger version (107K):
[in this window]
[in a new window]
 
Figure 5. NeuN (brown) images (a), the density of mature neurons (b), Bodian’s silver stain (blue) (c), the neurites density (d), and images of TUNEL (brown) (e), in the cortex after 48-hour SD. The cortical layers (a), neuron density (b), or neurite density (c,d) were not affected by 48-hour SD. TUNEL+ cells (arrows) were only detected around the KCl needle cavity (Ndl; counter-stain: methyl green) (e). A TUNEL+ cell with apoptotic cell bodies (in magnified window) (e). Magnification: (d) left: x100, right: x600; (e) x100, or x600, originally. Bar: 100 µm, x100, or 20 µm, x600.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
*Discussion
down arrowReferences
 
The safety of prolonged (48-hour) SD for the normal brain in the morphological perspective was demonstrated, as was the safety of brief (4 to 5 hours) SD.21 Administration of MK-801 abolished increases in new neuron density in the SVZ after 48-hour KCl infusion (Figure 2c), indicating that SD propagation, but not KCl diffusion, activates neurogenesis in the SVZ. The volume of localized cerebral necrosis plus edema caused by 48-hour KCl infusion was measured as 5.98 mm3 (average),13 limited to 0.9% of the total hemispheric volume.

Cells in mitosis (dividing cells) increased in the SVZ after prolonged SD, whereas RMS size was constant, indicating that the increase in BrdUrd+ (divided) cell densities was caused by an increased cell division rate in the SVZ, but not by altered rostral migration/cell accumulation in the RMS.22 Or, prolonged SD may have reduced the naturally occurring cell death rate in the dividing cells in the SVZ.

Brief (4-hour) SD increased new neurons, but not divided cell density, in the SVZ. Recurrent SDs are known to increase BDNF levels in the brain,23,24 which promotes the survival and differentiation of neurons,25 but they do not affect mitosis of precursor cells.26 The increase in new neurons in the SVZ after brief or prolonged SD may be caused, at least partially, by BDNF-derived promotion of neuronal differentiation and/or survival. Determining the precise relationship between the duration of SD and the dividing or survival potential of those cells, ie, whether there is a threshold SD period, or whether these responses are simply exaggerated by extending the duration of SD, requires further investigation.

After prolonged SD, the delayed increase in divided cells in the RMS or RMS size (Figure 2d) is considered to be the result of the earlier increase in dividing cell density in SVZ. It is unknown why the divided cell ratio in the SVZ did not increase at days 3 to 6 (Table) at the time when the total or divided cell density increased. The activated neurogenesis in SVZ may have reduced the rostral migration27 temporarily, resulting in accumulation of earlier divided (BrdUrd-negative) cells in the SVZ.

BrdUrd+/GFAP cells in clusters (hot spots) in the SVZ (Figure 3a) are thought to be neural (immature) precursors and their daughter cells (newborn neuroblasts).28 Neural precursors in hot spots have been considered as an intermediate proliferating population between newborn neuroblasts and GFAP+ neural progenitors (primary precursors).28,29 Neural progenitors, which can give rise to neurospheres in vitro, are relatively quiescent in vivo.29

The structures that produced ectopic new neuron-like cells (double-labeled by markers for divided and early committed neurons)—the caudate putamen, the cortical layer V-VI, and the anterior cingulate cortex—may have the potential for accepting new neurons from the SVZ, as was observed after induced apoptosis30 or cerebral ischemia.31,32 However, these ectopic new neuron-like cells did not express the marker for migrating neuroblasts, at least for 12 days, suggesting that these cells are not migrating or differentiating as new neurons in the SVZ. Because the SVZ is one of the most primitive structures in the phylogeny of the central nervous system,33 these relatively primitive structures may possess latent neural progenitors. Neural progenitors (in vitro) have been identified in the striatum34 or cortex35 of the adult rat brain.

Although the physiological significance of SD is currently unknown, SD may be an intrinsic mechanism functioning as an activator of endogenous neurogenesis. Elucidation of the survivability and reconstructive potential of the ectopic new neuron-like cells produced by SDs is needed, along with efforts to develop a practical SD induction method to facilitate therapeutic reconstruction of an impaired central nervous system.


*    Acknowledgments
 
This study was supported by a grant-in-aid for Scientific Research, from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan. We are thankful for the valuable assistance of Tomoko Yasuda, Ayako Yamada, Natsue Sakata, Mihoko Kurimoto, and Koji Nishimori. We also gratefully acknowledge the advice of Katsuyuki Simizu and Manabu Deguchi (Applied Medical Research), and Keiji Machino and Takemasa Bando (Bando).

Received January 10, 2005; revision received February 25, 2005; accepted March 21, 2005.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
*References
 
1. Kaplan MS, Hinds JW. Neurogenesis in the adult rat: electron microscopic analysis of light radioautographs. Science. 1977; 197: 1092–1094.[Abstract/Free Full Text]

2. Altman J. Autoradiographic and histological studies of postnatal neurogenesis. IV. Cell proliferation and migration in the anterior forebrain, with special reference to persisting neurogenesis in the olfactory bulb. J Comp Neurol. 1969; 137: 433–457.[CrossRef][Medline] [Order article via Infotrieve]

3. Lois C, Alvarez-Buylla A. Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia. Proc Natl Acad Sci U S A. 1993; 90: 2074–2077.[Abstract/Free Full Text]

4. Parent JM, Yu TW, Leibowitz RT, Geschwind DH, Sloviter RS, Lowenstein DH. Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus. J Neurosci. 1997; 17: 3727–3738.[Abstract/Free Full Text]

5. Parent JM, Valentin VV, Lowenstein DH. Prolonged seizures increase proliferating neuroblasts in the adult rat subventricular zone-olfactory bulb pathway. J Neurosci. 2002; 22: 3174–3188.[Abstract/Free Full Text]

6. Liu J, Solway K, Messing RO, Sharp FR. Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils. J Neurosci. 1998; 18: 7768–7778.[Abstract/Free Full Text]

7. Weinstein DE, Burrola P, Kilpatrick TJ. Increased proliferation of precursor cells in the adult rat brain after targeted lesioning. Brain Res. 1996; 743: 11–16.[CrossRef][Medline] [Order article via Infotrieve]

8. Leão AAP. Spreading depression of activity in the cerebral cortex. J Neurophysiol. 1944; 7: 359–390.[Free Full Text]

9. Bures J, Buresová O, Krivánek J. The Mechanism and Applications of Leão’s Spreading Depression of Electroencephalographic Activity. Prague: Academia; 1974.

10. Hartings JA, Rolli ML, Lu XC, Tortella FC. Delayed secondary phase of peri-infarct depolarizations after focal cerebral ischemia. J Neurosci. 2003; 23: 11602–11610.[Abstract/Free Full Text]

11. Hartings JA, Williams AJ, Bautista CC, Tortella FC. Penetrating brain injury in the rat: electroencephalography and persistence of spreading depression. Soc Neurosci. 2004; 793: 14.[Abstract].

12. Nellgard B, Wieloch T. NMDA-receptor blockers but not NBQX, an AMPA-receptor antagonist, inhibit spreading depression in the rat brain. Acta Physiol Scand. 1992; 146: 497–503.[Medline] [Order article via Infotrieve]

13. Yanamoto H, Hashimoto N, Nagata I, Kikuchi H. Infarct tolerance against temporary focal ischemia following spreading depression in rat brain. Brain Res. 1998; 784: 239–249.[CrossRef][Medline] [Order article via Infotrieve]

14. Johansson CB, Momma S, Clarke DL, Risling M, Lendahl U, Frisén J. Identification of a neural stem cell in the adult mammalian central nervous system. Cell. 1999; 96: 25–34.[CrossRef][Medline] [Order article via Infotrieve]

15. Matsumoto K, Moriuchi T, Koji T, Nakane PK. Molecular cloning of cDNA coding for rat proliferating cell nuclear antigen (PCNA)/cyclin. EMBO J. 1987; 6: 637–642.[Medline] [Order article via Infotrieve]

16. Gratzner HG. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine. Science. 1982; 218: 474–475.[Abstract/Free Full Text]

17. Moody SA, Quigg MS, Frankfurter A. Development of the peripheral trigeminal system in the chick revealed by an isotype-specific anti-beta-tubulin monoclonal antibody. J Comp Neurol. 1989; 279: 567–580.[CrossRef][Medline] [Order article via Infotrieve]

18. Brown JP, Couillard-Despres S, Cooper-Kuhn CM, Winkler J, Aigner L, Kuhn HG. Transient expression of doublecortin during adult neurogenesis. J Comp Neurol. 2003; 467: 1–10.[CrossRef][Medline] [Order article via Infotrieve]

19. Sterio DC. The unbiased estimation of number and sizes of arbitrary particles using the dissector. J Microsc. 1984; 134: 127–136.[Medline] [Order article via Infotrieve]

20. Gundersen HJG, Jensen B. Particle sizes and their distributions estimated from line-and point-sampled intercepts. Including graphical unfolding. J Microsc. 1983; 131: 291–310.

21. Nedergaard M, Hansen AJ. Spreading depression is not associated with neuronal injury in the normal brain. Brain Res. 1988; 449: 395–398.[CrossRef][Medline] [Order article via Infotrieve]

22. Kirschenbaum B, Doetsch F, Lois C, Alvarez-Buylla A. Adult subventricular zone neuronal precursors continue to proliferate and migrate in the absence of the olfactory bulb. J Neurosci. 1999; 19: 2171–2180.[Abstract/Free Full Text]

23. Kokaia Z, Gido G, Ringstedt T, Bengzon J, Kokaia M, Siesjö BK, Persson H, Lindvall O. Rapid increase of BDNF mRNA levels in cortical neurons following spreading depression. Brain Res Mol Brain Res. 1993; 19: 277–286.[Medline] [Order article via Infotrieve]

24. Yanamoto H, Mizuta I, Nagata I, Xue J-H, Zhang Z, Kikuchi H. Infarct tolerance accompanied enhanced BDNF-like immunoreactivity in neuronal nuclei. Brain Res. 2000; 877: 331–344.[CrossRef][Medline] [Order article via Infotrieve]

25. Alderson RF, Alterman AL, Barde Y-A, Lindsay RM. Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture. Neuron. 1990; 5: 297–306.[CrossRef][Medline] [Order article via Infotrieve]

26. Kirschenbaum B, Goldman SA. Brain-derived neurotrophic factor promotes the survival of neurons arising from the adult rat forebrain subependymal zone. Proc Natl Acad Sci U S A. 1995; 92: 210–214.[Abstract/Free Full Text]

27. Kuhn HG, Winkler J, Kempermann G, Thal LJ, Gage FH. Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J Neurosci. 1997; 17: 5820–5829.[Abstract/Free Full Text]

28. Doetsch F, Caillé I, Lim DA, García-Verdugo J-M, Alvarez-Buylla A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell. 1999; 97: 703–716.[CrossRef][Medline] [Order article via Infotrieve]

29. Morshead CM, Reynolds BA, Craig CG, McBurney MW, Staines WA, Morassutti D, Weiss S, van der Kooy D. Neural stem cells in the adult mammalian forebrain: a relatively quiescent subpopulation of subependymal cells. Neuron. 1994; 13: 1071–1082.[CrossRef][Medline] [Order article via Infotrieve]

30. Magavi SS, Leavitt BR, Macklis JD. Induction of neurogenesis in the neocortex of adult mice. Nature. 2000; 405: 951–955.[CrossRef][Medline] [Order article via Infotrieve]

31. Parent JM, Vexler ZS, Gong C, Derugin N, Ferriero DM. Rat forebrain neurogenesis and striatal neuron replacement after focal stroke. Ann Neurol. 2002; 52: 802–813.[CrossRef][Medline] [Order article via Infotrieve]

32. Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med. 2002; 8: 963–970.[CrossRef][Medline] [Order article via Infotrieve]

33. Poliakov GI. Structural organization of the human cerebral cortex during ontogenetic development. In: Sarkisov SA, Filimonov IN, Preobrazenskaya NS, ed. Cytoarchitectonics of the Cerebral Cortex in Man. Moscow, Russia: MEDGIZ; 1949: 33–92.

34. Palmer TD, Ray J, Gage FH. FGF-2-responsive neuronal progenitors reside in proliferative and quiescent regions of the adult rodent brain. Mol Cell Neurosci. 1995; 6: 474–486.[CrossRef][Medline] [Order article via Infotrieve]

35. Palmer TD, Markakis EA, Willhoite AR, Safar F, Gage FH. Fibroblast growth factor-2 activates a latent neurogenic program in neural stem cells from diverse regions of the adult CNS. J Neurosci. 1999; 19: 8487–8497.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
StrokeHome page
J.-H. Xue, H. Yanamoto, Y. Nakajo, N. Tohnai, Y. Nakano, T. Hori, K. Iihara, and S. Miyamoto
Induced Spreading Depression Evokes Cell Division of Astrocytes in the Subpial Zone, Generating Neural Precursor-Like Cells and New Immature Neurons in the Adult Cerebral Cortex
Stroke, November 1, 2009; 40(11): e606 - e613.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. Urbach, C. Redecker, and O. W. Witte
Induction of Neurogenesis in the Adult Dentate Gyrus by Cortical Spreading Depression
Stroke, November 1, 2008; 39(11): 3064 - 3072.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G. Kronenberg, C. Harms, R. W. Sobol, F. Cardozo-Pelaez, H. Linhart, B. Winter, M. Balkaya, K. Gertz, S. B. Gay, D. Cox, et al.
Folate Deficiency Induces Neurodegeneration and Brain Dysfunction in Mice Lacking Uracil DNA Glycosylase
J. Neurosci., July 9, 2008; 28(28): 7219 - 7230.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
R. W. H. Verwer, A. A. Sluiter, R. A. Balesar, J. C. Baayen, D. P. Noske, C. M. F. Dirven, J. Wouda, A. M. van Dam, P. J. Lucassen, and D. F. Swaab
Mature astrocytes in the adult human neocortex express the early neuronal marker doublecortin
Brain, December 1, 2007; 130(12): 3321 - 3335.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
V. Gupta
Silent or non-clinical infarct-like lesions in the posterior circulation territory in migraine: brain hypoperfusion or hyperperfusion?
Brain, January 1, 2006; 129(1): E39 - E39.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/7/1544    most recent
01.STR.0000169903.09253.c7v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yanamoto, H.
Right arrow Articles by Kikuchi, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yanamoto, H.
Right arrow Articles by Kikuchi, H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*POTASSIUM CHLORIDE
Related Collections
Right arrow Other Stroke Treatment - Medical